DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹296,045 Cr | ₹1,984 Cr |
What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹2,191 Cr |
| Mar2025 | ₹1,600 Cr |
| Mar2024 | ₹1,824 Cr |
| Mar2023 | ₹296,045 Cr |
| Mar2022 | ₹1,984 Cr |
How is Consolidated Net Profit of DIVIS LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,191 Cr | 36.94 | |
| Mar2025 | ₹1,600 Cr | -12.28 | |
| Mar2024 | ₹1,824 Cr | -99.38 | |
| Mar2023 | ₹296,045 Cr | 14,819.44 | |
| Mar2022 | ₹1,984 Cr | - | |
Compare Consolidated Net Profit of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹251,561.3 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| MANKIND PHARMA | ₹105,120.0 Cr | 3.4% | 6.6% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.3% |
2.2% |
57.5% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses